Schafer Cullen Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-5,895
| Closed | -$214K | – | 293 |
|
|
2016
Q4 | $214K | Sell |
5,895
-4,670
| -44% | -$170K | ﹤0.01% | 273 |
|
|
2016
Q3 | $486K | Buy |
10,565
+3,205
| +44% | +$147K | 0.01% | 221 |
|
|
2016
Q2 | $370K | Sell |
7,360
-36,095
| -83% | -$1.81M | ﹤0.01% | 237 |
|
|
2016
Q1 | $2.33M | Sell |
43,455
-10,632
| -20% | -$569K | 0.03% | 147 |
|
|
2015
Q4 | $3.55M | Sell |
54,087
-18,025
| -25% | -$1.18M | 0.04% | 131 |
|
|
2015
Q3 | $4.07M | Sell |
72,112
-75,443
| -51% | -$4.26M | 0.05% | 133 |
|
|
2015
Q2 | $8.72M | Buy |
147,555
+63
| +0% | +$3.72K | 0.09% | 98 |
|
|
2015
Q1 | $9.19M | Buy |
147,492
+17,677
| +14% | +$1.1M | 0.09% | 92 |
|
|
2014
Q4 | $7.47M | Sell |
129,815
-59,330
| -31% | -$3.41M | 0.09% | 89 |
|
|
2014
Q3 | $10.2M | Sell |
189,145
-530
| -0.3% | -$28.5K | 0.1% | 84 |
|
|
2014
Q2 | $9.94M | Sell |
189,675
-2,967
| -2% | -$156K | 0.09% | 88 |
|
|
2014
Q1 | $10.2M | Buy |
192,642
+92,510
| +92% | +$4.89M | 0.1% | 88 |
|
|
2013
Q4 | $4.01M | Buy |
100,132
+12,511
| +14% | +$501K | 0.04% | 172 |
|
|
2013
Q3 | $3.31M | Buy |
87,621
+2,812
| +3% | +$106K | 0.04% | 190 |
|
|
2013
Q2 | $3.33M | Buy |
+84,809
| New | +$3.33M | 0.04% | 176 |
|